Evidence map›Paper›PMID 34218165›Full record

ArticleDiagnostic microbiology and infectious disease2021

Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay.

Robert F Potter, Brooj Abro, Charles S Eby, Carey-Ann D Burnham, Neil W Anderson, Bijal A Parikh

Open access · greenAbstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Robert F PotterDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Brooj AbroDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Charles S EbyDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
Carey-Ann D BurnhamDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA; Departments of Pediatrics and Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Neil W AndersonDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: nwanderson@wustl.edu.
Bijal A ParikhDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: bparikh@wustl.edu.
Washington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (C

Indexed as

Age FactorsAmbulatory CareCOVID-19COVID-19 Nucleic Acid TestingEmergency Medical ServicesHospitalizationHumansMissouriPharynxRetrospective StudiesSARS-CoV-2Viral LoadClinical virologyMolecular assaysSARS-CoV-2

Identifiers

PMID34218165
PMCPMC9761777
OpenAlexW3154755735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.